Questcor is the only company that sells Acthar, because they bought the rights of the drug in 2001. "In 2007, it raised the price overnight, to more than $23,000 a vial, from $1,650, bringing the cost of a typical course of treatment for infantile spasms to above $100,000". Since Questcor had a monopoly of this industry, they were able to raise the price of their drug a whopping 14 times above the original price.
14 TIMES!!!!! To make matters worse, since Acthar is the only medication for infantile spasms, patients with this disease must pay the hefty price. And to even complicate matters further, Questcor began stating that Acthar is a successful drug for other conditions. However, since Acthar was created before the Food and Drug Administration required testing to prove that the drug worked, it did not have to be tested. In other words, people were paying $23,000 a vial for a drug that they didn't know even worked.
What kind of world do we live in where a company can mark up prices 14 times the original and then say that it cures other diseases when there is no proof? This is absurd! Recently, insurance companies said they would not pay for Acthar for patients unless it was treating infantile spasms. This prevents Questcor from selling Acthar for other conditions that there is no proof of the medicine working on. Despite this, Questcor was able to get away with selling their drug in the first place.
Although we live in tough economic times, nothing warrants a company to completely deceive the public in a maniacal way. Unfortunately, there are no repercussions for Questcor because they did not break any rules. This is the reason that the government tries to protect industries from monopolies. As a country, we NEED to do a better job containing these companies that think they can beat the system.
What repercussions do you think Questcor deserves, if at all? And do you think tough economic times warrant a company to hike prices this much? Please comment below.